These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33682296)

  • 1. Presumed neuroprotective therapies prescribed by veterinary ophthalmologists for canine degenerative retinal and optic nerve diseases.
    Hopper RG; Montiani-Ferreira F; da Silva Pereira J; Fritz MC; Ruggiero VJ; Sapienza JS; Kato K; Komáromy AM
    Vet Ophthalmol; 2021 May; 24(3):229-239. PubMed ID: 33682296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveying veterinary ophthalmologists to assess the advice given to owners of pets with irreversible blindness.
    Somma AT; Montiani-Ferreira F; Schafaschek AI; Gatti L; Featherstone H
    Vet Rec; 2020 Aug; 187(4):e30. PubMed ID: 32532841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden acquired retinal degeneration syndrome (SARDS) - a review and proposed strategies toward a better understanding of pathogenesis, early diagnosis, and therapy.
    Komáromy AM; Abrams KL; Heckenlively JR; Lundy SK; Maggs DJ; Leeth CM; MohanKumar PS; Petersen-Jones SM; Serreze DV; van der Woerdt A
    Vet Ophthalmol; 2016 Jul; 19(4):319-31. PubMed ID: 26096588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of consensus on consensual response.
    Stonex TM; Bartoe JT; Aguirre GD
    Vet Ophthalmol; 2018 Jan; 21(1):104-107. PubMed ID: 28378446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography and molecular analysis of sudden acquired retinal degeneration syndrome (SARDS) eyes suggests the immune-mediated nature of retinal damage.
    Grozdanic SD; Lazic T; Kecova H; Mohan K; Kuehn MH
    Vet Ophthalmol; 2019 May; 22(3):305-327. PubMed ID: 30109754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic anti-glaucoma therapy in dogs with primary glaucoma: A practitioner survey of current medical protocols.
    Plummer CE; Bras D; Grozdanic S; Komáromy AM; McLellan G; Miller P; Sapienza JS; Teixeira L; Webb T
    Vet Ophthalmol; 2021 Mar; 24 Suppl 1():96-108. PubMed ID: 32920915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of retinal morphology of canine sudden acquired retinal degeneration syndrome using optical coherence tomography and fluorescein angiography.
    Osinchuk SC; Leis ML; Salpeter EM; Sandmeyer LS; Grahn BH
    Vet Ophthalmol; 2019 Jul; 22(4):398-406. PubMed ID: 30136357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presumed cancer-associated retinopathy (CAR) mimicking Sudden Acquired Retinal Degeneration Syndrome (SARDS) in canines.
    Grozdanic SD; Lazic T; Kecova H; Mohan K; Adamus G; Kuehn MH
    Vet Ophthalmol; 2021 Mar; 24(2):125-155. PubMed ID: 33369040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice patterns in the management of acute intervertebral disc herniation in dogs.
    Moore SA; Early PJ; Hettlich BF
    J Small Anim Pract; 2016 Aug; 57(8):409-15. PubMed ID: 27256593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine sudden acquired retinal degeneration syndrome: Owner perceptions on the time to vision loss, treatment outcomes, and prognosis for life.
    Washington DR; Li Z; Fox LC; Mowat FM
    Vet Ophthalmol; 2021 Mar; 24(2):156-168. PubMed ID: 33377263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral blindness presumed as sudden acquired retinal degeneration syndrome (SARDS) in one Dachshund and four Maltese dogs.
    Susanti L; Kwon D; Ahn J; Seo K; Kang S
    Vet Ophthalmol; 2023 Mar; 26(2):169-175. PubMed ID: 36647151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Blindness.
    Meekins JM
    Top Companion Anim Med; 2015 Sep; 30(3):118-25. PubMed ID: 26494503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the use of a colorimetric pupil light reflex device in the diagnosis of fundus disease or optic pathway disease in dogs.
    Terakado K; Yogo T; Nezu Y; Harada Y; Hara Y; Tagawa M
    J Vet Med Sci; 2013 Nov; 75(11):1491-5. PubMed ID: 23774038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection for treatment of glaucoma in adults.
    Sena DF; Lindsley K
    Cochrane Database Syst Rev; 2013 Feb; 2(2):CD006539. PubMed ID: 23450569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of canine glaucoma therapy.
    Komáromy AM; Bras D; Esson DW; Fellman RL; Grozdanic SD; Kagemann L; Miller PE; Moroi SE; Plummer CE; Sapienza JS; Storey ES; Teixeira LB; Toris CB; Webb TR
    Vet Ophthalmol; 2019 Sep; 22(5):726-740. PubMed ID: 31106969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of systemic antimicrobial prescribing for dogs by Victorian veterinarians.
    Barzelai ID; Whittem T
    Aust Vet J; 2017 Oct; 95(10):375-385. PubMed ID: 28948625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The British Veterinary Association-Kennel Club progressive retinal atrophy scheme.
    Barnett KC
    Vet Rec; 1970 May; 86(20):588-92. PubMed ID: 5463257
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term outcome of sudden acquired retinal degeneration syndrome in dogs.
    Stuckey JA; Pearce JW; Giuliano EA; Cohn LA; Bentley E; Rankin AJ; Gilmour MA; Lim CC; Allbaugh RA; Moore CP; Madsen RW
    J Am Vet Med Assoc; 2013 Nov; 243(10):1425-31. PubMed ID: 24171371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection for treatment of glaucoma in adults.
    Sena DF; Ramchand K; Lindsley K
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006539. PubMed ID: 20166085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection for treatment of glaucoma in adults.
    Sena DF; Lindsley K
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006539. PubMed ID: 28122126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.